A leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions.
Its innovative products include rapid tests for
the detection of antibodies to HIV and HCV at the point of care and testing
solutions for detecting various drugs of abuse. In addition, the Company is a
leading provider of oral fluid sample collection, stabilization and preparation
products for molecular diagnostic applications.
OraSure's portfolio of products is sold globally
to various clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research and academic
institutions, distributors, government agencies, physicians' offices, and
commercial and industrial entities. The Company's products enable healthcare
providers to deliver critical information to patients, empowering them to make
decisions to improve and protect their health.
More
on
